Get the Stockscreener App
1.1096
0.04%
-0.0004
After Hours:
1.11
0.0004
+0.04%
Therapeuticsmd Inc stock is traded at $1.1096, with a volume of 11,014.
It is down -0.04% in the last 24 hours and up +0.42% over the past month.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
See More
Previous Close:
$1.11
Open:
$1.11
24h Volume:
11,014
Relative Volume:
0.45
Market Cap:
$12.84M
Revenue:
$996.00K
Net Income/Loss:
$-6.09M
P/E Ratio:
-2.0936
EPS:
-0.53
Net Cash Flow:
$-9.76M
1W Performance:
+2.74%
1M Performance:
+0.42%
6M Performance:
+44.18%
1Y Performance:
-38.01%
1-Day Range:
$1.09
$1.126
1-Week Range:
$1.06
$1.24
52-Week Range:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Name
Therapeuticsmd Inc
Sector
Phone
561-961-1900
Address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.1096 | 12.73M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-20 | Downgrade | Jefferies | Hold → Underperform |
| May-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-02-19 | Initiated | Guggenheim | Buy |
| Oct-17-19 | Initiated | H.C. Wainwright | Buy |
| Apr-30-19 | Resumed | Noble Capital Markets | Outperform |
| Jun-15-18 | Initiated | JP Morgan | Overweight |
| Sep-08-17 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-11-17 | Upgrade | Oppenheimer | Perform → Outperform |
| May-09-17 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-22-16 | Resumed | Jefferies | Buy |
| Nov-22-16 | Initiated | Oppenheimer | Outperform |
| Nov-07-16 | Resumed | Guggenheim | Buy |
| Apr-04-16 | Initiated | Goldman | Buy |
| Dec-08-15 | Reiterated | Jefferies | Buy |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Sep-21-15 | Reiterated | Jefferies | Buy |
| Jun-09-15 | Initiated | Guggenheim | Buy |
| Jul-08-14 | Initiated | FBR Capital | Outperform |
| Apr-17-14 | Reiterated | Noble Financial | Buy |
| Jan-28-14 | Reiterated | Noble Financial | Buy |
View All
Therapeuticsmd Inc Stock (TXMD) Latest News
Live market analysis of TherapeuticsMD Inc.Insider Selling & Free Expert Verified Stock Movement Alerts - Newser
Is TherapeuticsMD Inc. stock poised for growthTrade Analysis Summary & Community Verified Swing Trade Signals - Newser
TherapeuticsMD Inc. stock momentum explainedQuarterly Profit Summary & Long-Term Safe Investment Ideas - Newser
Momentum divergence signals in TherapeuticsMD Inc. chartChart Signals & High Conviction Buy Zone Picks - Newser
What machine learning models say about TherapeuticsMD Inc.Market Risk Summary & Daily Entry Point Trade Alerts - Newser
Will TherapeuticsMD Inc. stock recover after recent dropQuarterly Risk Review & AI Optimized Trading Strategy Guides - Newser
TherapeuticsMD Inc. stock trend forecast2025 Earnings Surprises & Long-Term Investment Growth Plans - Newser
What indicators show strength in TherapeuticsMD Inc.Buy Signal & Community Verified Trade Alerts - Newser
Relative strength of TherapeuticsMD Inc. in sector analysisJuly 2025 Update & Short-Term Swing Trade Alerts - Newser
Will breakout in TherapeuticsMD Inc. lead to full recoveryRisk Management & Stepwise Trade Signal Implementation - Newser
Published on: 2025-09-11 23:46:09 - Newser
What technical models suggest about TherapeuticsMD Inc.’s comebackMarket Growth Summary & Expert Curated Trade Ideas - Newser
How to escape a deep drawdown in TherapeuticsMD Inc.Trend Reversal & Free Safe Capital Growth Stock Tips - Newser
Visual analytics tools that track TherapeuticsMD Inc. performance2025 Top Decliners & AI Based Buy and Sell Signals - Newser
Using portfolio simulators with TherapeuticsMD Inc. includedEarnings Recap Report & AI Driven Stock Reports - Newser
Risk vs reward if holding onto TherapeuticsMD Inc.July 2025 Fed Impact & Consistent Profit Focused Trading Strategies - Newser
Applying big data sentiment scoring on TherapeuticsMD Inc.Quarterly Risk Review & Weekly Market Pulse Alerts - Newser
Applying sector rotation models to TherapeuticsMD Inc.July 2025 Patterns & Risk Controlled Swing Alerts - Newser
Is a relief rally coming for TherapeuticsMD Inc. holdersEarnings Recap Summary & High Conviction Buy Zone Alerts - Newser
Advanced analytics toolkit walkthrough for TherapeuticsMD Inc.Stop Loss & Daily Entry Point Trade Alerts - Newser
Automated trading signals detected on TherapeuticsMD Inc.Market Risk Summary & Expert Verified Movement Alerts - Newser
TherapeuticsMD Inc. stock trend outlook and recovery pathJuly 2025 Trade Ideas & AI Powered Market Entry Ideas - Newser
Tools to monitor TherapeuticsMD Inc. recovery probabilityJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - Newser
Can volume confirm reversal in TherapeuticsMD Inc.July 2025 Macro Moves & Capital Protection Trading Alerts - Newser
How to track smart money flows in TherapeuticsMD Inc.Stop Loss & Verified Stock Trade Ideas - Newser
What to do if you’re stuck in TherapeuticsMD Inc.July 2025 Pullbacks & Capital Efficient Trade Techniques - Newser
Has TherapeuticsMD Inc. found a price floorJuly 2025 Summary & Daily Stock Trend Reports - Newser
Published on: 2025-09-09 04:08:51 - Newser
Therapeuticsmd Inc Stock (TXMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):